Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. (From -To) 19 Jan 04 -18 Jan 07
REPORT DATE (DD-MM-YYYY)
01-02-2007
REPORT TYPE
Final
DATES COVERED
SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR'S ACRONYM(S)
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012
SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENTApproved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACTSex hormone-binding globulin (SHBG) is a plasma protein that binds androgens, and it acts as a transducer of androgen signaling at the plasma membrane of prostate cancer cells. The human prostate cancer cell line, LNCaP, in addition to having a receptor for SHBG (RSHBG), produces its own SHBG. We devised an inducible system to study SHBG protein expression in LNCaP cells, and expressed tagged versions of SHBG in LNCaP cells, that will also be useful for future studies on its biologic function. We present a complex and novel picture of extrahepatic human SHBG gene expression, including 21 different SHBG gene transcripts generated by alternative splicing, 17 of which are newly described, and the use of three independent SHBG gene promoters, including a novel promoter, PN. We used microarray technology to investigate the effect of SHBG on the DHT response of LNCaP cells, and found evidence for RSHBG signaling and SHBG modulation of AR activity. Further extended studies of the role of SHBG in prostate signaling and the modulation of SHBG expression in prostate cancer are warranted.